|
|
Volumn 3, Issue 2, 2004, Pages 153-158
|
|
Pharmaceutical stability testing conference
|
|
Author keywords
Pharmaceutical stability; Product development; Regulatory filing; Stability testing; Testing protocols
|
|
Indexed keywords
CYCLODEXTRIN;
EXCIPIENT;
FOSINOPRIL;
POLYGLACTIN;
RECOMBINANT PROTEIN;
STABILIZING AGENT;
VACCINE;
VIRUS ANTIGEN;
ANALYTIC METHOD;
CASE STUDY;
CLINICAL STUDY;
CONFERENCE PAPER;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG QUALITY;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SOLUTION;
DRUG STABILITY;
EUROPE;
HUMAN;
MOLECULAR SIZE;
PROCESSING;
RISK MANAGEMENT;
SOLID STATE;
UNITED KINGDOM;
UNITED STATES;
DRUG APPROVAL;
DRUG LEGISLATION;
PHARMACEUTICS;
DRUG APPROVAL;
DRUG STABILITY;
EUROPE;
LEGISLATION, DRUG;
TECHNOLOGY, PHARMACEUTICAL;
UNITED STATES;
|
|
EID: 2342528461
PISSN: 14740338
EISSN: None
Source Type: Journal
DOI: 10.1517/14740338.3.2.153 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
